Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Use of infliximab in pregnancy.

Mahadevan U, Kane S.

Am J Gastroenterol. 2010 Jan;105(1):219; author reply 219-20. doi: 10.1038/ajg.2009.532. No abstract available.

PMID:
20054309
2.

Use of infliximab in particular clinical settings: management based on current evidence.

Papa A, Mocci G, Bonizzi M, Felice C, Andrisani G, De Vitis I, Guidi L, Gasbarrini A.

Am J Gastroenterol. 2009 Jun;104(6):1575-86. doi: 10.1038/ajg.2009.162. Epub 2009 Apr 28. Review.

PMID:
19491875
3.
4.

Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.

Shah B, Mayer L.

Expert Rev Clin Immunol. 2010 Jul;6(4):607-20. doi: 10.1586/eci.10.45. Review.

5.

[CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].

Wedekind S.

MMW Fortschr Med. 2011 Dec 1;153(48):54-5. German. No abstract available.

PMID:
22299262
6.

Review and clinical perspectives for the use of infliximab in ulcerative colitis.

Panaccione R, Fedorak RN, Aumais G, Bernard EJ, Bernstein CN, Bitton A, Croitoru K, Dieleman LA, Enns R, Feagan BG, Franchimont D, Greenberg GR, Griffiths AM, Marshall JK, Pare P, Patel S, Penner R, Render C, Seidman E, Steinhart AH.

Can J Gastroenterol. 2008 Mar;22(3):261-72. Review.

7.

Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.

[No authors listed]

Prescrire Int. 2007 Oct;16(91):194.

PMID:
17926832
8.

Infliximab anaphylaxis in siblings.

Teich N.

Inflamm Bowel Dis. 2011 Aug;17(8):E108. doi: 10.1002/ibd.21778. Epub 2011 May 12. No abstract available.

PMID:
21567666
9.

[Use of TNFalpha antibodies in treatment of inflammatory bowel disease].

Martinsen TC, Herter R, Dybdahl JH, Waldum HL.

Tidsskr Nor Laegeforen. 2010 Feb 11;130(3):273-7. doi: 10.4045/tidsskr.09.0642. Review. Norwegian.

10.

Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal.

Regadas FS, Pinto RA, Murad-Regadas SM, Canedo JA, Leal M, Nogueras JJ, Wexner SD.

Colorectal Dis. 2011 May;13(5):555-60. doi: 10.1111/j.1463-1318.2010.02186.x.

PMID:
20070344
11.

Is infliximab effective for induction of remission in patients with ulcerative colitis?

Lichtenstein GR.

Inflamm Bowel Dis. 2001 May;7(2):89-93. No abstract available.

PMID:
11383596
12.

[Inflammatory bowel diseases--new therapeutic options].

Herrlinger K, Stange EF.

Med Klin (Munich). 2008 Feb 15;103(2):90-101; quiz 102-3. doi: 10.1007/s00063-008-1013-3. German. No abstract available.

PMID:
18270665
13.

[Biological therapy as treatment of inflammatory bowel diseases].

Agnholt J.

Ugeskr Laeger. 2008 Jun 9;170(24):2152-6. Danish.

PMID:
18565302
14.

Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis.

Aratari A, Margagnoni G, Koch M, Papi C.

J Crohns Colitis. 2011 Jun;5(3):262. doi: 10.1016/j.crohns.2011.02.004. Epub 2011 Mar 10. No abstract available.

PMID:
21575893
15.

Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.

Lacruz-Guzmán D, Torres-Moreno D, Pedrero F, Romero-Cara P, García-Tercero I, Trujillo-Santos J, Conesa-Zamora P.

Eur J Clin Pharmacol. 2013 Mar;69(3):431-8. doi: 10.1007/s00228-012-1389-0. Epub 2012 Sep 8.

PMID:
22960943
16.

Immunogenicity of infliximab: how to handle the problem?

Baert F, De Vos M, Louis E, Vermeire S; Belgian IBD Research Group.

Acta Gastroenterol Belg. 2007 Apr-Jun;70(2):163-70. Review.

PMID:
17715629
17.

Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.

Lee TW, Fedorak RN.

Gastroenterol Clin North Am. 2010 Sep;39(3):543-57. doi: 10.1016/j.gtc.2010.08.018. Review.

PMID:
20951917
18.

Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease.

Grosen A, Julsgaard M, Kelsen J, Christensen LA.

J Crohns Colitis. 2014 Feb;8(2):175-6. doi: 10.1016/j.crohns.2013.09.003. Epub 2013 Oct 3. No abstract available.

PMID:
24090905
19.

Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?

Burakoff R.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S202-3. doi: 10.1002/ibd.20729. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816760
20.

Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease.

Steenholdt C, Bendtzen K, Brynskov J, Thomsen OØ, Ainsworth MA.

Scand J Gastroenterol. 2011 Mar;46(3):310-8. doi: 10.3109/00365521.2010.536254. Epub 2010 Nov 18.

PMID:
21087119

Supplemental Content

Support Center